Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity

Immunological Reviews

Volumn 158, Issue , 1997, Pages 147-157

  Jensen, Eric R ^a   Shen, Hao ^a   Wettstein, Felix O ^a   Ahmed, Rafi ^b   Miller, Jeff F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CD8 ANTIGEN; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; IMMUNOLOGICAL MEMORY; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION;

ANIMALS; COTTONTAIL RABBIT PAPILLOMAVIRUS; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS; MICE; PAPILLOMAVIRUS INFECTIONS; RABBITS; TUMOR VIRUS INFECTIONS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030863783     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01001.x     Document Type: Review

References (85)

1. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-163.
2. Tilney LG, Portnoy DA. Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol 1989;109:1597-1608.
3. Sheehan B, et al. Molecular and genetic determinants of the Listeria monocytogenes infectious process. Curr Top Microbiol Immunol 1994;192: 187-216.
4. Mackaness GB. Cellular resistance to infection. J Exp Med 1962;116:381-406.
5. Lane FC, Unanue ER. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med 1972;135:1104-1112.
6. Conlan JW, North RJ. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J Exp Med 1991;174:741-744.
7. Daugelat S, Ladel CH, Schoel B, Kaufmann SH. Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection. Infect Immun 1994;62:1881-1888.
8. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 1991;124:5-24.
9. Dunn PL, North RJ. Resolution of primary murine listeriosis and acquired resistance to lethal secondary infection can be mediated predominantly by Thy-1+ CD4- CD8- cells. J Infect Dis 1991;164:869-877.
10. Portnoy DA. Innate immunity to a facultative intracellular bacterial pathogen. Curr Opin Immunol 1992;4:20-24.
11. North RJ. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med 1970;132:521-534.
12. de Chastellier C, Berche P. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect Immun 1994;62:543-553.
13. Czuprynski CJ, Henson PM, Campbell PA. Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol 1984;35:193-208.
14. Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991;353:852-855.
15. Pamer EG. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 1994;152:686-694.
16. Sanderson S, Campbell DJ, Shastri N. Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J Exp Med 1995;182:1751-1757.
17. Harty JT, Bevan MJ. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992;175:1531-1538.
18. Harty JT, Pamer EG. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J Immunol 1995;154:4642-4650.
19. Bouwer HGA, Nelson CS, Gibbins BL, Protnoy DA, Hinrichs DJ. Listeriolysin O is a target of the immune response to Listeria monocytogenes. J Exp Med 1992;175:1467-1471.
20. Kuhn M, Goebel W. Induction of cytokines in phagocytic mammalian cells infected with virulent and avirulent Listeria strains. Infect Immun 1994;62:348-356.
21. Tripp CS, Kanagawa O, Unanue ER. Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12. J Immunol 1995;135:3427-3432.
22. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
23. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD 14-dependent pathway. Infect Immun 1996;64:1906-1912.
24. Mielke ME, Ehlers S, Hahn H. The role of cytokines in experimental listeriosis. Immunobiology 1993;189:285-315.
25. Biron CA, Orange JS. IL12 in acute viral infectious disease. Res Immunol 1993;146:590-600.
26. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-237.
27. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-4027.
28. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
29. Schafer R, Portnoy DA, Brassell SA, Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 1992;149:53-59.
30. Ikonomidis G, Paterson Y, Kos FJ, Portnoy DA. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J Exp Med 1994;180:2209-2218.
31. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, Miller JF. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci USA 1995;92:3987-3991.
32. Goossens PL, Milon G, Cossart P, Saron MF. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int Immunol 1995;7:797-805.
33. Frankel FR, Hegde S, Lieberman J, Paterson Y. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J Immunol 1995;155:4775-4782.
34. Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med 1995;1:471-477.
35. Vazquez-Boland J, et al. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithinase in cell-to-cell spread. Infect Immun 1992;60:219-230.
36. Whitton JL, et al. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol 1989;63:4303-4310.
37. Schulz M, et al. Major histocompatibility complex-dependent T cell epitopes of lympohocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur J Immunol 1989;19:1657-1667.
38. Leimeister-Wachter M, Domann E, Chakraborty T. The expression of virulence genes in Listeria monocytogenes is thermoregulated. J Bacteriol 1992;174:947-952.
39. Freitag NE, Youngman P, Portnoy DA. Transcriptional activation of the Listeria monocytogenes hemolysin gene in Bacillus subtilis. J Bacteriol 1992;174:1293-1298.
40. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
41. Byrne JA, Oldstone MB. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol 1984;51:682-686.
42. Moskophidis D, Cobbold SP, Waldmann H, Lehmann-Grube F. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J Virol 1987;61:1867-1874.
43. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994;369:648-652.
44. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979;27:51-177.
45. Ahmed R. Immunological memory against viruses. Semin Immunol 1992;4:105-109.
46. Ahmed R, Butler LD, Bhatti L. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J Virol 1988;62:2102-2106.
47. Ahmed R, Jamieson BD, Porter DD. Immune therapy of a persistent and disseminated viral infection. J Virol 1987;61:3920-3929.
48. Jamieson BD, Butler LD, Ahmed R. Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells. J Virol 1987;61:3930-3937.
49. van der Most RG, et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol 1996;157:5543-5554.
50. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 1984;160:521-540.
51. Ahmed R, Hahn CS, Somasundaram T, Villarete L, Matloubian M, Strauss JH. Molecular basis of organ-specific selection of viral variants during chronic infection. J Virol 1991;65:4242-4247.
52. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol 1993;67:7340-7349.
53. Kyburz D, Speiser DE, Battegay M, Hengartner H, Zinkernagel RM. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Eur J Immunol 1993;23:1540-1545.
54. Slifka MK, Shen H, Matloubian M, Jensen ER, Miller JF, Ahmed R. Antiviral cytotoxic T-cell memory by vaccination with recombinant listeria monocytogenes. J Virol 1996;70:2902-2910.
55. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-406.
56. Pan ZK, Ikonomidis G, Pardoll D, Paterson Y. Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine. Cancer Res 1995;55:4776-4779.
57. Wettstein FO. Papillomaviruses and carcinogenic progression I: Cottontail rabbit (Shope) papillomavirus. In: Salzman N, Howley PM, eds. The Papovaviridae, Vol. 2. New York: Plenum Publishing Corp; 1987. p. 167-186.
58. Brandsma JL. Animal models of human-papillomavirus-associated oncogenesis. Intervirology 1994;37:189-200.
59. Okabayashi M, Angell MG, Christensen ND, Kreider JW. Morphometric analysis and identification of infiltrating leucocytes in regressing and progressing Shope rabbit papillomas. Int J Cancer 1991;49:919-923.
60. Altmann A, Jochmus I, Rosl F. Intra- and extracellular control mechanisms of human papillomavirus infection. Intervirology 1994;37:180-188.
61. Lin YL, Borenstein LA, Ahmed R, Wettstein FO. Cottontail rabbit papillomavirus L1 protein-based vaccines: Protection is achieved only with a full-length, nondenatured product. J Virol 1993;67:4154-4162.
62. Evans C, Ito AY. Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits III. Response to reinfection with viral nucleic acid. J Natl Cancer Inst 1966;36:1161-1166.
63. Selvakumar R, Borenstein LA, Lin Y, Ahmed R, Wettstein FO. Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J Virol 1995;69:602-605.
64. Paterson Y, Ikonomidis G. Recombinant Listeria monocytogenes cancer vaccines. Curr Opin Immunol 1996;8:664-669.
65. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991;55:476-511.
66. Kocks C, Gouin E, Tabouret M, Berche P, Ohayon H, Cossart P. L. monocytogenes-induced actin assembly requires the actA gene product, a surface protein. Cell 1992;68:521-531.
67. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988;167:1459-1471.
68. Barry RA, Bouwer HG, Portnoy DA, Hinrichs DJ. Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect Immun 1992;60:1625-1632.
69. Gouin E, Mengaud J, Cossart P. The virulence gene cluster of Listeria monocytogenes is also present in Listeria ivanovii, an animal pathogen, and Listeria seeligeri, a nonpathogenic species. Infect Immun 1994;62:3550-3553.
70. Darji A, Chakraborty T, Niebuhr K, Tsonis N, Wehland J, Weiss S. Hyperexpression of listeriolysin in the nonpathogenic species Listeria innocua and high yield purification. J Biotechnol 1995;43:205-212.
71. Kocks C, et al. The unrelated surface proteins ActA of Listeria monocytogenes and IcsA of Shigella flexneri are sufficient to confer actin-based motility on Listeria innocua and Escherichia coli respectively. Mol Microbiol 1995;18:413-423.
72. Lammerding AM, Glass KA, Gendron-Fitzpatrick A, Doyle MP. Determination of virulence of different strains of Listeria monocytogenes and Listeria innocua by oral inoculation of pregnant mice. Appl Environ Microbiol 1992;58: 3991-4000.
73. Schwan WR, Demuth A, Kuhn M, Goebel W. Phosphatidylinositol-specific phospholipase C from Listeria monocytogenes contributes to intracellular survival and growth of Listeria innocua. Infect Immun 1994;62:4795-4803.
74. Falzano L, et al. Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol 1993;9:1247-1254.
75. Varshavsky A. The N-end rule. Cell 1992;69:725-735.
76. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993;363:552-554.
77. Townsend A, et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988;168:1211-1224.
78. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986;14:4683-4690.
79. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
80. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243-246.
81. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993;361:359-362.
82. Jondal M, Schirmbeck R, Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996;5:295-302.
83. Hess J, et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996;93:1458-1463.
84. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983;65:109-121.
85. Taguchi T, et al. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods 1990;128:65-73.